Association of surgical approach with complication rate, progression-free survival time, and disease-specific survival time in cats with mammary adenocarcinoma: 107 cases (1991–2014)

Francesco Gemignani Department of Animal Medicine, Production and Health, University of Padova, 35122 Padova PD, Italy.

Search for other papers by Francesco Gemignani in
Current site
Google Scholar
PubMed
Close
 DVM
,
Philipp D. Mayhew Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616.

Search for other papers by Philipp D. Mayhew in
Current site
Google Scholar
PubMed
Close
 BVM&S
,
Michelle A. Giuffrida Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616.

Search for other papers by Michelle A. Giuffrida in
Current site
Google Scholar
PubMed
Close
 VMD
,
Jason Palaigos Matthew J. Ryan Veterinary Hospital, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19103.

Search for other papers by Jason Palaigos in
Current site
Google Scholar
PubMed
Close
,
Jeffrey J. Runge Matthew J. Ryan Veterinary Hospital, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19103.

Search for other papers by Jeffrey J. Runge in
Current site
Google Scholar
PubMed
Close
 VMD
,
David E. Holt Department of Clinical Studies, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19103.

Search for other papers by David E. Holt in
Current site
Google Scholar
PubMed
Close
 BVSc
,
Nicholas A. Robertson Flint Animal Cancer Center, Colorado State University, Fort Collins, CO 80523.

Search for other papers by Nicholas A. Robertson in
Current site
Google Scholar
PubMed
Close
,
Bernard Seguin Flint Animal Cancer Center, Colorado State University, Fort Collins, CO 80523.

Search for other papers by Bernard Seguin in
Current site
Google Scholar
PubMed
Close
 DVM
,
Meaghan Walker Department for Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada.

Search for other papers by Meaghan Walker in
Current site
Google Scholar
PubMed
Close
,
Ameet Singh Department for Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada.

Search for other papers by Ameet Singh in
Current site
Google Scholar
PubMed
Close
 DVM
,
Julius M. Liptak Alta Vista Animal Hospital, 2616 Bank St, Gloucester, ON K1T 1M9, Canada.

Search for other papers by Julius M. Liptak in
Current site
Google Scholar
PubMed
Close
 BVSc, MVetClinStud
,
Giorgio Romanelli Clinica Veterinario Nerviano, Via Giulio Cesare Lampugnani, 3, 20014 Nerviano MI, Italy.

Search for other papers by Giorgio Romanelli in
Current site
Google Scholar
PubMed
Close
 DVM
,
Marina Martano Department of Animal Pathology, School of Veterinary Medicine, University of Turin, 10124 Torino TO, Italy.

Search for other papers by Marina Martano in
Current site
Google Scholar
PubMed
Close
 DVM
,
Sarah E. Boston Department of Small Animal Clinical Studies, College of Veterinary Medicine, University of Florida, Gainesville, FL, 32610.

Search for other papers by Sarah E. Boston in
Current site
Google Scholar
PubMed
Close
 DVM
,
Cassie Lux Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, TN 37996.

Search for other papers by Cassie Lux in
Current site
Google Scholar
PubMed
Close
 DVM
,
Roberto Busetto Department of Animal Medicine, Production and Health, University of Padova, 35122 Padova PD, Italy.

Search for other papers by Roberto Busetto in
Current site
Google Scholar
PubMed
Close
 DVM
,
William T. N. Culp Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616.

Search for other papers by William T. N. Culp in
Current site
Google Scholar
PubMed
Close
 VMD
,
Katherine A. Skorupski Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616.

Search for other papers by Katherine A. Skorupski in
Current site
Google Scholar
PubMed
Close
 DVM
, and
Jenna H. Burton Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616.

Search for other papers by Jenna H. Burton in
Current site
Google Scholar
PubMed
Close
 DVM

Abstract

OBJECTIVE To evaluate potential associations between surgical approach and complication rate, progression-free survival time, and disease-specific survival time in cats with mammary adenocarcinoma.

DESIGN Retrospective case series.

ANIMALS 107 client-owned cats.

PROCEDURES Medical records of cats that underwent surgical excision of mammary adenocarcinoma by means of a unilateral or bilateral (staged or single-session) mastectomy at 9 hospitals between 1991 and 2014 were reviewed. Relevant clinicopathologic data and details of surgical and adjuvant treatments were recorded. Outcome data were obtained, including postoperative complications, progression-free survival time, and disease-specific survival time.

RESULTS Complications occurred in 12 of 61 (19.7%) cats treated with unilateral mastectomy, 5 of 14 (35.7%) cats treated with staged bilateral mastectomy, and 13 of 32 (40.6%) cats treated with single-session bilateral mastectomy. Complications were significantly more likely to occur in cats undergoing bilateral versus unilateral mastectomy. Median progression-free survival time was longer for cats treated with bilateral mastectomy (542 days) than for cats treated with unilateral mastectomy (289 days). Significant risk factors for disease progression included unilateral mastectomy, tumor ulceration, lymph node metastasis, and tumors arising in the fourth mammary gland. Significant risk factors for disease-specific death included lymph node metastasis and development of regional or distant metastasis. Among cats that did not develop metastasis, unilateral mastectomy was a significant risk factor for disease-specific death. Treatment with chemotherapy was associated with a significantly decreased risk of disease-specific death.

CONCLUSIONS AND CLINICAL RELEVANCE Results supported bilateral mastectomy for the treatment of mammary adenocarcinoma in cats to improve progression-free and disease-specific survival time. Performing bilateral mastectomy in a staged fashion may help to decrease the complication rate.

Abstract

OBJECTIVE To evaluate potential associations between surgical approach and complication rate, progression-free survival time, and disease-specific survival time in cats with mammary adenocarcinoma.

DESIGN Retrospective case series.

ANIMALS 107 client-owned cats.

PROCEDURES Medical records of cats that underwent surgical excision of mammary adenocarcinoma by means of a unilateral or bilateral (staged or single-session) mastectomy at 9 hospitals between 1991 and 2014 were reviewed. Relevant clinicopathologic data and details of surgical and adjuvant treatments were recorded. Outcome data were obtained, including postoperative complications, progression-free survival time, and disease-specific survival time.

RESULTS Complications occurred in 12 of 61 (19.7%) cats treated with unilateral mastectomy, 5 of 14 (35.7%) cats treated with staged bilateral mastectomy, and 13 of 32 (40.6%) cats treated with single-session bilateral mastectomy. Complications were significantly more likely to occur in cats undergoing bilateral versus unilateral mastectomy. Median progression-free survival time was longer for cats treated with bilateral mastectomy (542 days) than for cats treated with unilateral mastectomy (289 days). Significant risk factors for disease progression included unilateral mastectomy, tumor ulceration, lymph node metastasis, and tumors arising in the fourth mammary gland. Significant risk factors for disease-specific death included lymph node metastasis and development of regional or distant metastasis. Among cats that did not develop metastasis, unilateral mastectomy was a significant risk factor for disease-specific death. Treatment with chemotherapy was associated with a significantly decreased risk of disease-specific death.

CONCLUSIONS AND CLINICAL RELEVANCE Results supported bilateral mastectomy for the treatment of mammary adenocarcinoma in cats to improve progression-free and disease-specific survival time. Performing bilateral mastectomy in a staged fashion may help to decrease the complication rate.

All Time Past Year Past 30 Days
Abstract Views 894 0 0
Full Text Views 4480 1725 148
PDF Downloads 3474 1172 98
Advertisement